Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

Autor: Issa, Ghayas C., Aldoss, Ibrahim, Thirman, Michael J., DiPersio, John, Arellano, Martha, Blachly, James S., Mannis, Gabriel N., Perl, Alexander, Dickens, David S., McMahon, Christine M., Traer, Elie, Zwaan, C. Michel, Grove, Carolyn S., Stone, Richard, Shami, Paul J., Mantzaris, Ioannis, Greenwood, Matthew, Shukla, Neerav, Cuglievan, Branko, Kovacsovics, Tibor
Zdroj: Journal of Clinical Oncology; 1/1/2025, Vol. 43 Issue 1, p75-84, 13p
Databáze: Supplemental Index